Indinavir [clinicaltrials_resource:e870e5be883a13f15c112ddb4640cbf0]
eligibility for clinicaltrials:NCT01835145 [clinicaltrials_resource:22853b78666e9653a2ef02f18dcab961]eligibility for clinicaltrials:NCT00107536 [clinicaltrials_resource:273f28a85c6566d76ff76854cd53b9fb]eligibility for clinicaltrials:NCT00134069 [clinicaltrials_resource:31c44eb02996a6c0ff1a0b62791f3b16]eligibility for clinicaltrials:NCT00617708 [clinicaltrials_resource:5779b97f6e8f19f4261bc4fbf6ffca8f]eligibility for clinicaltrials:NCT02066181 [clinicaltrials_resource:b75bbb3aebffbab9512c0286dff621a7]eligibility for clinicaltrials:NCT00070525 [clinicaltrials_resource:bbc57e24ec459e18f6e64dc2c331a766]eligibility for clinicaltrials:NCT00119236 [clinicaltrials_resource:d8177edb3af609f1c135ac1b3cd473fc]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113) [clinicaltrials:NCT00000804]A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months [clinicaltrials:NCT00000841]The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year [clinicaltrials:NCT00000848]The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy [clinicaltrials:NCT00000850]A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3 [clinicaltrials:NCT00000859]The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients [clinicaltrials:NCT00000861]A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone [clinicaltrials:NCT00000870]Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection [clinicaltrials:NCT00000875]Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults [clinicaltrials:NCT00000877]Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects [clinicaltrials:NCT00000882]Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 [clinicaltrials:NCT00000885]A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir [clinicaltrials:NCT00000892]A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients [clinicaltrials:NCT00000896]Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children [clinicaltrials:NCT00000901]Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [clinicaltrials:NCT00000903]A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [clinicaltrials:NCT00000912]A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks [clinicaltrials:NCT00000914]A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood [clinicaltrials:NCT00000916]A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [clinicaltrials:NCT00000918]A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection [clinicaltrials:NCT00000919]A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART) [clinicaltrials:NCT00000922]Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 [clinicaltrials:NCT00000923]A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants [clinicaltrials:NCT00000944]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001083]A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients [clinicaltrials:NCT00001084]A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [clinicaltrials:NCT00001086]A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir [clinicaltrials:NCT00001095]Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV [clinicaltrials:NCT00001119]Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir [clinicaltrials:NCT00001133]A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection [clinicaltrials:NCT00001443]clinicaltrials:NCT00001566A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC [clinicaltrials:NCT00002155]A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients [clinicaltrials:NCT00002168]The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection [clinicaltrials:NCT00002179]A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects. [clinicaltrials:NCT00002199]A Comparison of 141W94 and Indinavir in HIV-Infected Patients [clinicaltrials:NCT00002202]A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC [clinicaltrials:NCT00002208]Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir [clinicaltrials:NCT00002220]A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients [clinicaltrials:NCT00002223]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Indinavir [clinicaltrials_resource:e870e5be883a13f15c112ddb4640cbf0]
Bio2RDF identifier
e870e5be883a13f15c112ddb4640cbf0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e870e5be883a13f15c112ddb4640cbf0
identifier
clinicaltrials_resource:e870e5be883a13f15c112ddb4640cbf0
title
Indinavir
@en
type
label
Indinavir [clinicaltrials_resource:e870e5be883a13f15c112ddb4640cbf0]
@en